Ulrika Julku

M.Sc. (Pharm.)
PREP in Neurodegenerative Disorders Group Researcher
PhD student

Ulrika Julku started as a PhD student at the beginning of 2014. Her project focuses on clarifying the role of PREP on dopaminergic system, and the interplay between PREP, alpha-synuclein and dopaminergic neurotransmission.


M.Sc. (Pharm.),  University of Helsinki, 2013

  • Main subject pharmacology


Svacbahs R, Julku U, Norrbacka S, Myöhänen TT: Removal of prolyl oligopeptidase reduces alpha-synuclein toxicity in cells and in vivo. Scientific Reports 8: 1552, 2018

Julku U, Panhelainen AE, Tiilikainen SE, Svarcbahs R, Tammimäki AE, Piepponen TP, Savolainen MH, Myöhänen TT: Prolyl Oligopeptidase Regulates Dopamine Transporter Phosphorylation in the Nigrostriatal Pathway of Mouse. Molecular Neurobiology, 55: 470-482, 2018

Svarcbahs R, Julku U, Myöhänen TT: Inhibition of Prolyl Oligopeptidase Restores Spontaneous Motor Behavior in the α-Synuclein Virus Vector–Based Parkinson’s Disease Mouse Model by Decreasing α-Synuclein Oligomeric Species in Mouse Brain. Journal of Neuroscience

Leave a Reply

Your email address will not be published. Required fields are marked *